The transformation of radiation oncology using real-time magnetic resonance guidance: A review
William A. Hall(Medical College of Wisconsin), Christopher J. Schultz(The University of Texas MD Anderson Cancer Center), David A. Jaffray(University of Toronto), Arjun Sahgal(Sunnybrook Health Science Centre), Robbert J.H.A. Tersteeg(University Medical Center Utrecht), Bradley A. Erickson(Medical College of Wisconsin), Laura A. Dawson(University of Toronto), X. Allen Li(Medical College of Wisconsin), Ananya Choudhury(University of Manchester), Marcel Verheij(The Netherlands Cancer Institute), Clifton D. Fuller(The University of Texas MD Anderson Cancer Center), E.S. Paulson(Medical College of Wisconsin), Kevin J. Harrington(Royal Marsden NHS Foundation Trust), M. Bassetti(University of Wisconsin–Madison), Clifford G. Robinson(Washington University in St. Louis), Bruce D. Minsky(Harvard University), Bas W. Raaymakers(University Medical Center Utrecht), Parag J. Parikh(Henry Ford Hospital), Uulke A. van der Heide(The Netherlands Cancer Institute), J J W Lagendijk(University Medical Center Utrecht), Percy Lee(University of California, Los Angeles)
Cited by 182
Related Papers
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k
Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy—3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology
|Radiotherapy and Oncology|2006|1.6k
Genome-wide cell-free DNA fragmentation in patients with cancer
|Nature|2019|1.5k
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
|Journal of Clinical Oncology|2013|1.1k